NovaBridge Biosciences (NBP) Current Assets (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Current Assets data on file, last reported at $217.5 million in Q4 2025.

• Current Assets for Q4 2025 came in at $217.5 million, up 23.11% year-over-year; the trailing twelve-month figure through Dec 2025 was $217.5 million (up 23.11% YoY), and the FY2025 annual result was $217.5 million, up 23.11% from the prior year.
• Current Assets slipped to $217.5 million in Q4 2025 per NBP's latest filing, from $232.8 million in the prior quarter.
• Over five years, Current Assets peaked at $747.9 billion in Q4 2021 and troughed at $167.6 million in Q2 2025.
• A 5-year average of $57.8 billion and a median of $232.8 million in 2025 frame the typical range for Current Assets.
• The sharpest annual moves came in 2021 and 2022: Current Assets surged 92655.2% in 2021, then sank 99.93% in 2022.
• A 5-year view of Current Assets shows it stood at $747.9 billion in 2021, then slumped by 99.93% to $509.9 million in 2022, then slumped by 36.35% to $324.5 million in 2023, then plunged by 45.55% to $176.7 million in 2024, then gained by 23.11% to $217.5 million in 2025.
• Business Quant data shows NBP's Current Assets at $217.5 million in Q4 2025, $232.8 million in Q3 2025, and $167.6 million in Q2 2025.